This month on pharmaphorum, we explore the history of French pharmaceutical company Sanofi, which was created through many partnerships and acquisitions over a period of 100 years. Sanofi is one ...

French drug maker Sanofi on Friday posted stronger earnings growth than analysts had expected in the third quarter, helped by ...

The pharmaceutical company reported third-quarter earnings and sales that beat analysts’ expectations, boosted by ...

The emergence of regulatory concerns over the sale have hit Sanofi shares this week, and the company will be under pressure ...

French drug maker Sanofi on Friday posted stronger earnings growth than analysts had expected in the third quarter, boosted ...

Sanofi said the talks to sell 50% plus one share of what’s called Opella fits with the company’s broader strategy to focus on innovative medicines and vaccines. Steven Goldstein is based in ...

Regeneron (REGN) and Sanofi (SNY) announced that the European Commission, or EC, has approved Dupixent to treat eosinophilic esophagitis, or ...

Sanofi (SNY) has released an update. Sanofi’s Dupixent has received EU approval as the first treatment for children aged one to 11 with ...

Sanofi did not disclose any financial details of the potential deal, and said further updates would be provided in due course. Shares in the group were down 0.46% at 0717 GMT. The company said in ...

(Reuters) - French drug maker Sanofi on Friday posted stronger earnings ... estimate of 4 billion euros in a poll posted on the company's website. Vaccines sales rose a currency-adjusted 25.5 ...